Cyclin D1 expression is predictive of occult metastases in head and neck cancer patients with clinically negative cervical lymph nodes

被引:0
|
作者
Capaccio, P
Pruneri, G
Carboni, N
Pagliari, AV
Quatela, M
Cesana, BM
Pignataro, L
机构
[1] Univ Milan, Osped Maggiore, Dipartimento Sci Otorinolaringol, IRCCS, I-20122 Milan, Italy
[2] Osped Maggiore, Serv Anat Patol 2, IRCCS, Milan, Italy
[3] Osped Maggiore, IRCCS, Lab Epidemiol, Milan, Italy
关键词
cyclin D1; p53; immunohistochemistry; head and neck cancer; occult metastases;
D O I
10.1002/(SICI)1097-0347(200005)22:3<234::AID-HED5>3.0.CO;2-3
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. The aim of this study was to investigate the Value of p53 and cyclin Df gene expression in predicting the risk of occult lymph node metastases in patients with head and neck squamous cell carcinoma (HNSCC). Methods. The expression of cyclin D1 and p53 was evaluated by means of immunohistochemical analysis in 32 HNSCC patients with clinically and radiologically negative lymph nodes in whom metastatic involvement was subsequently demonstrated at histologic examination (pN+). A group of 64 head and neck cancer patients with histologically negative laterocervical lymph nodes (pN0) was used as a control. Results. Cyclin D1 and p53 expression were observed respectively in 42 (43.7%) and 48 cases (50%). Cyclin D1 expression significantly correlated with tumor extension and advanced clinical stage (p = .002 and p = .001, respectively). At univariate regression analysis, cyclin D1 expression significantly correlated with the presence of occult lymph node metastases (p = .0007), and it remained an independent predictor at multivariate regression analysis (p = .0059). Conclusions. Our study indicates that the expression of cyclin D1 correlates with the presence of occult cervical metastases in head and neck carcinoma patients, thus suggesting that its immunohistochemical evaluation in biopsy samples may be used as an additional tool for identifying patients to be treated with elective neck dissection. (C) 2000 John Wiley & Sons, Inc.
引用
收藏
页码:234 / 240
页数:7
相关论文
共 50 条
  • [41] CYTOPLASMIC CYCLIN D1 IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN PATIENTS WITH LYMPH NODE METASTASES AT RADICAL PROSTATECTOMY FOR PROSTATE CANCER
    Fleischmann, Achim
    Rocha, Carla
    Seculic, Nikolina
    Zlobec, Inti
    Sauter, Guido
    Thalmann, George N.
    JOURNAL OF UROLOGY, 2010, 183 (04): : E826 - E826
  • [42] Incidence of occult lymph node metastasis in patients with head and neck cancer
    Kirat, Onur
    Pinarbasli, Mehmet Ozgur
    Gurbuz, Melek Kezban
    Kaya, Ercan
    Ozudogru, Erkan
    ENT UPDATES, 2016, 6 (01): : 43 - 45
  • [43] Cyclin D1 expression in breast cancer patients and tamoxifen therapy
    Filipits, M.
    Rudas, M.
    Lehnert, M.
    Kubista, E.
    Dietze, O.
    Greil, R.
    Lax, S.
    Samonigg, H.
    Jakesz, R.
    Gnant, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [44] Cyclin D1 gene expression in human cervical neoplasia
    Nichols, GE
    Williams, ME
    Gaffey, MJ
    Stoler, MH
    MODERN PATHOLOGY, 1996, 9 (04) : 418 - 425
  • [45] The risk of nodal metastases in breast cancer patients with clinically negative lymph nodes: a population-based analysis
    Voogd, AC
    Coebergh, JWW
    van Driel, OJR
    Roumen, RMH
    van Beek, MWP
    Vreugdenhil, A
    Crommelin, MA
    BREAST CANCER RESEARCH AND TREATMENT, 2000, 62 (01) : 63 - 69
  • [46] The risk of nodal metastases in breast cancer patients with clinically negative lymph nodes: a population-based analysis
    Adri C. Voogd
    Jan-Willem W. Coebergh
    Ocker J. Repelaer van Driel
    Rudi M.H. Roumen
    Mike W.P.M. van Beek
    Art Vreugdenhil
    Mariad A. Crommelin
    Breast Cancer Research and Treatment, 2000, 62 : 63 - 69
  • [47] Expression Of Cyclin D1 Protein Isoforms And Its Prognostic Significance In Cervical Cancer
    Gu, Jiahui
    Zhang, Xinyu
    Yang, Zhuo
    Wang, Ning
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 9073 - 9083
  • [48] Assessment and management of lymph node metastases in the neck in head and neck cancer patients
    vandenBrekel, MWM
    Leemans, CR
    Snow, GB
    CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1996, 22 (03) : 175 - 182
  • [49] Analysis of Cyclin D1 G870A Polymorphism in Patients with Head and Neck Cancers
    Demokan, Semra
    Suoglu, Yusufhan
    Ulusan, Murat
    Dalay, Nejat
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2011, 31 (06): : 1435 - 1441
  • [50] Immunohistochemical expression of glucose transporter Glut1 and cyclin D1 in breast carcinomas with negatine lymph nodes
    Ravazoula, P
    Batistatou, A
    Aletra, C
    Ladopoulos, J
    Kourounis, G
    Tzigounis, B
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2003, 24 (06) : 544 - 546